Diaceutics PLC (AIM: DXRX)
Health Care · Life Sciences Tools & Services · GB
£2.03
-0.25% today · +25.3% 1Y
Diaceutics PLC (AIM: DXRX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $228.03M.
Over the last twelve months the share price has gained 25.3%, trading between 1.25 and 2.00.
Tweenvest scores Diaceutics PLC across four factors: quality 74/100, value 59/100, growth 99/100. Its strongest factor is growth.
DXRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $228.03M
- Revenue (TTM)
- $54.83M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- £2.00
- 52-week low
- £1.25
- Avg volume (3M)
- —
- Shares outstanding
- 84.89M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Penetrium Bioscience Inc.KOSDAQ: A187660 | $257.45M | ₩6,320.00 | -9.97% |
| Vimta Labs LimitedBSE: 524394 | $248.09M | Rs537.15 | -7.97% |
| Lifecore Biomedical, Inc.NasdaqGS: LFCR | $244.15M | $6.44 | -0.16% |
| Dishman Carbogen Amcis LimitedNSEI: DCAL | $242.48M | Rs149.68 | -0.45% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.66 | -0.60% |
| BICO Group AB (publ)OM: BICO | $167.28M | Skr24.10 | +1.69% |
Figures last refreshed Oct 11, 2026.